Evidence map›Paper›PMID 38587785›Full record

ArticleEndocrine2024

Landscape of congenital adrenal hyperplasia cases in adult endocrinology clinics of Türkiye-a nation-wide multicentre study.

Melek Eda Ertorer, Inan Anaforoglu, Nusret Yilmaz, Gamze Akkus, Seda Turgut, Kursad Unluhizarci, Ozlem Soyluk Selcukbiricik, Fatma Avci Merdin, Ersen Karakilic, Esma Pehlivan and 18 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Endocrine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Rare Types of Congenital Adrenal Hyperplasias Other Than 21-hydroxylase DeficiencyJournal of clinical research in pediatric endocrinology · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Melek Eda ErtorerBaskent University Faculty of Medicine, Endocrinology and Metabolism, Adana, Turkey.
Inan AnaforogluMehmet Ali Aydınlar University Faculty of Medicine, Endocrinology and Metabolism, Istanbul, Turkey. ianaforoglu@hotmail.com.
Nusret YilmazAkdeniz University Faculty of Medicine, Endocrinology and Metabolism, Antalya, Turkey.
Gamze AkkusCukurova University Faculty of Medicine, Endocrinology and Metabolism, Adana, Turkey.
Seda TurgutUniversity of Health Sciences, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Endocrinology and Metabolism, Istanbul, Turkey.
Kursad UnluhizarciErciyes University Faculty of Medicine, Endocrinology and Metabolism, Kayseri, Turkey.
Ozlem Soyluk SelcukbiricikIstanbul University Faculty of Medicine, Endocrinology and Metabolism, Istanbul, Turkey.
Fatma Avci MerdinAnkara University Faculty of Medicine, Endocrinology and Metabolism, Ankara, Turkey.
Ersen KarakilicCanakkale 18 Mart University Faculty of Medicine, Endocrinology and Metabolism, Canakkale, Turkey.
Esma PehlivanEge University Faculty of Medicine, Endocrinology and Metabolism, Izmir, Turkey.
Goknur YorulmazEskisehir Osmangazi University Faculty of Medicine, Endocrinology and Metabolism, Eskisehir, Turkey.
Ozen Oz GulUludag University Faculty of Medicine, Endocrinology and Metabolism, Bursa, Turkey.
Rifat EmralAnkara University Faculty of Medicine, Endocrinology and Metabolism, Ankara, Turkey.
Medine Nur KebapciEskisehir Osmangazi University Faculty of Medicine, Endocrinology and Metabolism, Eskisehir, Turkey.
Fettah AcubucuUniversity of Health Sciences, Adana Training and Research Hospital, Endocrinology and Metabolism, Adana, Turkey.
Dilek TuzunK. Maras Sutcu Imam University Faculty of Medicine, Endocrinology and Metabolism, K.Maras, Turkey.
Suheyla GorarUniversity of Health Sciences, Antalya Training and Research Hospital, Endocrinology and Metabolism, Antalya, Turkey.
Emek TopuzK. Maras Sutcu Imam University Faculty of Medicine, Endocrinology and Metabolism, K.Maras, Turkey.
Gulay Simsek BagirBaskent University Faculty of Medicine, Endocrinology and Metabolism, Adana, Turkey.
Selin Dincer GencInonu University Faculty of Medicine, Endocrinology and Metabolism, Malatya, Turkey.
Kezban DemirIstanbul Medeniyet University Faculty of Medicine, Endocrinology and Metabolism, Istanbul, Turkey.
Gonca TamerIstanbul Medeniyet University Faculty of Medicine, Endocrinology and Metabolism, Istanbul, Turkey.
Guzin YaylaliPamukkale University Faculty of Medicine, Endocrinology and Metabolism, Denizli, Turkey.
Tulay OmmaUniversity of Health Sciences, Ankara Training and Research Hospital, Endocrinology and Metabolism, Ankara, Turkey.
Sevde Nur FiratUniversity of Health Sciences, Ankara Training and Research Hospital, Endocrinology and Metabolism, Ankara, Turkey.
Gonul KocUniversity of Health Sciences, Ankara Training and Research Hospital, Endocrinology and Metabolism, Ankara, Turkey.
Emre Sedar SaygiliCanakkale 18 Mart University Faculty of Medicine, Endocrinology and Metabolism, Canakkale, Turkey.
Banu Sarer YurekliEge University Faculty of Medicine, Endocrinology and Metabolism, Izmir, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsCongenital adrenal hyperplasia (CAH) is a group of disorders that affect the production of steroids in the adrenal gland and are inherited in an autosomal recessive pattern. The clinical and biochemical manifestations of the disorder are diverse, ranging from varying degrees of anomalies of the external genitalia to life-threatening adrenal insufficiency. This multicenter study aimed to determine the demographics, biochemical, clinical, and genetic characteristics besides the current status of adult patients with CAH nationwide.

methodsThe medical records of 223 patients with all forms of CAH were evaluated in the study, which included 19 adult endocrinology clinics. A form inquiring about demographical, etiological, and genetic (where available) data of all forms of CAH patients was filled out and returned by the centers.

resultsAmong 223 cases 181 (81.16%) patients had 21-hydroxylase deficiency (21OHD), 27 (12.10%) had 11-beta-hydroxylase deficiency (110HD), 13 (5.82%) had 17-hydroxylase deficiency (17OHD) and 2 (0.89%) had 3-beta-hydroxysteroid-dehydrogenase deficiency. 21OHD was the most prevalent CAH form in our national series. There were 102 (56.4%) classical and 79 (43.6%) non-classical 210HD cases in our cohort. The age of the patients was 24.9 ± 6.1 (minimum-maximum: 17-44) for classical CAH patients and 30.2 ± 11.2 (minimum-maximum: 17-67). More patients in the nonclassical CAH group were married and had children. Reconstructive genital surgery was performed in 54 (78.3%) of classical CAH females and 42 (77.8%) of them had no children. Thirty-two (50.8%) NCAH cases had homogenous and 31 (49.2%) had heterogeneous CYP21A2 gene mutations. V281L pathological variation was the most prevalent mutation, it was detected in 35 (55.6%) of 21OHD NCAH patients.

conclusionOur findings are compatible with the current literature except for the higher frequency of 110HD and 17OHD, which may be attributed to unidentified genetic causes. A new classification for CAH cases rather than classical and non-classical may be helpful as the disease exhibits a large clinical and biochemical continuum. Affected cases should be informed of the possible complications they may face. The study concludes that a better understanding of the clinical characteristics of patients with CAH can improve the management of the disorder in daily practice.

Indexed as

Adrenal Hyperplasia, CongenitalAdolescentAdultAgedEndocrinologyFemaleHumansMaleMiddle AgedYoung Adult11-beta-hydroxylase deficiency17-alpha-hydroxylase deficiency21-hydroxylase deficiencyadultCongenital adrenal hyperplasiaTürkiye

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.